Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17176 - 17200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Clofibrate	Approved Withdrawn	PPARGC1A	10891	upregulated	Clofibrate results in increased expression of PPARGC1A mRNA	4p15.2	A20645
Clofibrate	Approved Withdrawn	SOD1	6647	downregulated	Clofibrate results in decreased expression of SOD1 mRNA	21q22.11	A21679
Clofibrate	Approved Withdrawn	SREBF1	6720	upregulated	Clofibrate results in increased expression of SREBF1 mRNA	17p11.2	A20645
Clomifene	Approved Investigational	ABHD2	11057	downregulated	Clomiphene results in decreased expression of ABHD2 mRNA	15q26.1	A21106
Clomifene	Approved Investigational	CA12	771	downregulated	Clomiphene results in decreased expression of CA12 mRNA	15q22.2	A21106
Clomifene	Approved Investigational	CCND1	595	downregulated	Clomiphene results in decreased expression of CCND1 mRNA	11q13.3	A21106
Clomifene	Approved Investigational	CCNG2	901	upregulated	Clomiphene results in increased expression of CCNG2 mRNA	4q21.1	A21106
Clomifene	Approved Investigational	CXCL12	6387	downregulated	Clomiphene results in decreased expression of CXCL12 mRNA	10q11.21	A21106
Clomifene	Approved Investigational	CYP3A4	1576	upregulated	[Clomiphene results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA	7q22.1	A21466
Clomifene	Approved Investigational	EFNA1	1942	upregulated	Clomiphene results in increased expression of EFNA1 mRNA	1q22	A21106
Clomifene	Approved Investigational	EGR3	1960	downregulated	Clomiphene results in decreased expression of EGR3 mRNA	8p21.3	A21106
Clomifene	Approved Investigational	FOXC1	2296	downregulated	Clomiphene results in decreased expression of FOXC1 mRNA	6p25.3	A21106
Clomifene	Approved Investigational	ID3	3399	upregulated	Clomiphene results in increased expression of ID3 mRNA	1p36.12	A21106
Clomifene	Approved Investigational	JAK2	3717	downregulated	Clomiphene results in decreased expression of JAK2 mRNA	9p24.1	A21106
Clomifene	Approved Investigational	KYNU	8942	upregulated	Clomiphene results in increased expression of KYNU mRNA	2q22.2	A21106
Clomifene	Approved Investigational	LIF	3976	upregulated	Clomiphene results in increased expression of LIF mRNA	22q12.2	A21680
Clomifene	Approved Investigational	MYB	4602	downregulated	Clomiphene results in decreased expression of MYB mRNA	6q23.3	A21106
Clomifene	Approved Investigational	MYBL1	4603	downregulated	Clomiphene results in decreased expression of MYBL1 mRNA	8q13.1	A21106
Clomifene	Approved Investigational	NMRK1	54981	downregulated	Clomiphene results in decreased expression of NMRK1 mRNA	9q21.13	A21106
Clomifene	Approved Investigational	OLFM1	10439	downregulated	Clomiphene results in decreased expression of OLFM1 mRNA	9q34.3	A21106
Clomifene	Approved Investigational	PDZK1	5174	downregulated	Clomiphene results in decreased expression of PDZK1 mRNA	1q21.1	A21106
Clomifene	Approved Investigational	PIK3R3	8503	upregulated	Clomiphene results in increased expression of PIK3R3 mRNA	1p34.1	A21106
Clomifene	Approved Investigational	PRSS23	11098	downregulated	Clomiphene results in decreased expression of PRSS23 mRNA	11q14.2	A21106
Clomifene	Approved Investigational	PTGES	9536	downregulated	Clomiphene results in decreased expression of PTGES mRNA	9q34.11	A21106
Clomifene	Approved Investigational	RBBP8	5932	downregulated	Clomiphene results in decreased expression of RBBP8 mRNA	18q11.2	A21106

Displaying entries 17176 - 17200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability